125 related articles for article (PubMed ID: 17590405)
21. Developmental relationship between cytotoxic alpha/beta T cell receptor-positive intraepithelial lymphocytes and Peyer's patch lymphocytes.
Cuff CF; Cebra CK; Rubin DH; Cebra JJ
Eur J Immunol; 1993 Jun; 23(6):1333-9. PubMed ID: 8388798
[TBL] [Abstract][Full Text] [Related]
22. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles.
Vajdy M; Gardner J; Neidleman J; Cuadra L; Greer C; Perri S; O'Hagan D; Polo JM
J Infect Dis; 2001 Dec; 184(12):1613-6. PubMed ID: 11740739
[TBL] [Abstract][Full Text] [Related]
24. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice.
Lin SW; Hensley SE; Tatsis N; Lasaro MO; Ertl HC
J Clin Invest; 2007 Dec; 117(12):3958-70. PubMed ID: 18008010
[TBL] [Abstract][Full Text] [Related]
25. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
26. Induction of CD8+ T cells to an HIV-1 antigen upon oral immunization of mice with a simian E1-deleted adenoviral vector.
Pinto AR; Fitzgerald JC; Gao GP; Wilson JM; Ertl HC
Vaccine; 2004 Jan; 22(5-6):697-703. PubMed ID: 14741162
[TBL] [Abstract][Full Text] [Related]
27. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
[TBL] [Abstract][Full Text] [Related]
28. Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells.
Yashima S; Yoshizaki S; Shinoda K; Yoshida A; Kondo A; Mizuguchi H; Ryo A; Okuda K; Shimada M
Vaccine; 2010 Apr; 28(18):3257-64. PubMed ID: 20188679
[TBL] [Abstract][Full Text] [Related]
29. Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs.
Shu Y; Winfrey S; Yang ZY; Xu L; Rao SS; Srivastava I; Barnett SW; Nabel GJ; Mascola JR
Vaccine; 2007 Feb; 25(8):1398-408. PubMed ID: 17113201
[TBL] [Abstract][Full Text] [Related]
30. L-selectin is not essential for naive CD4 cell trafficking or development of primary responses in Peyer's patches.
Bradley LM; Malo ME; Tonkonogy SL; Watson SR
Eur J Immunol; 1997 May; 27(5):1140-6. PubMed ID: 9174603
[TBL] [Abstract][Full Text] [Related]
31. Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.
Ko SY; Cheng C; Kong WP; Wang L; Kanekiyo M; Einfeld D; King CR; Gall JG; Nabel GJ
J Virol; 2009 Jan; 83(2):748-56. PubMed ID: 18987146
[TBL] [Abstract][Full Text] [Related]
32. Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C.
Burgers WA; Shephard E; Monroe JE; Greenhalgh T; Binder A; Hurter E; Van Harmelen JH; Williamson C; Williamson AL
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):195-206. PubMed ID: 18240957
[TBL] [Abstract][Full Text] [Related]
33. Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice.
Wong SB; Siliciano RF
J Virol; 2005 Feb; 79(3):1701-12. PubMed ID: 15650195
[TBL] [Abstract][Full Text] [Related]
34. Route of adenovirus-based HIV-1 vaccine delivery impacts the phenotype and trafficking of vaccine-elicited CD8+ T lymphocytes.
Kaufman DR; Bivas-Benita M; Simmons NL; Miller D; Barouch DH
J Virol; 2010 Jun; 84(12):5986-96. PubMed ID: 20357087
[TBL] [Abstract][Full Text] [Related]
35. HSV-1 amplicon vectors elicit polyfunctional T cell responses to HIV-1 Env, and strongly boost responses to an adenovirus prime.
Duke CM; Maguire CA; Keefer MC; Federoff HJ; Bowers WJ; Dewhurst S
Vaccine; 2007 Oct; 25(42):7410-21. PubMed ID: 17868958
[TBL] [Abstract][Full Text] [Related]
36. Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.
Hovav AH; Cayabyab MJ; Panas MW; Santra S; Greenland J; Geiben R; Haynes BF; Jacobs WR; Letvin NL
J Virol; 2007 Jan; 81(1):74-83. PubMed ID: 17050608
[TBL] [Abstract][Full Text] [Related]
37. Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine.
Liu J; Wyatt LS; Amara RR; Moss B; Robinson HL
Vaccine; 2006 Apr; 24(16):3332-9. PubMed ID: 16472543
[TBL] [Abstract][Full Text] [Related]
38. Heterologous HIV-based lentiviral/adenoviral vectors immunizations result in enhanced HIV-specific immunity.
Asefa B; Korokhov N; Lemiale F
Vaccine; 2010 Apr; 28(20):3617-24. PubMed ID: 20051277
[TBL] [Abstract][Full Text] [Related]
39. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
[TBL] [Abstract][Full Text] [Related]
40. The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vector.
Millar J; Dissanayake D; Yang TC; Grinshtein N; Evelegh C; Wan Y; Bramson J
Cell Immunol; 2007; 250(1-2):55-67. PubMed ID: 18313652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
